Publication | Closed Access

Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide—a potential antileishmanial agent

Molecular PharmacologyMedicinal ChemistryBioorganic ChemistryBiochemistryAntiparasitic AgentNatural SciencesMedicineChemical BiologyPharmacologyPharmaceutical ChemistryDrug DiscoveryNovel Quinoline Derivative